{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:19:37Z","timestamp":1780427977172,"version":"3.54.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Artif. Intell."],"abstract":"<jats:p>Preclinical models are ubiquitous and essential for drug discovery, yet our understanding of how well they translate to clinical outcomes is limited. In this study, we investigate the translational success of treatments for <jats:italic>Clostridium difficile<\/jats:italic> infection from animal models to human patients. Our analysis shows that only 36% of the preclinical and clinical experiment pairs result in translation success. Univariate analysis shows that the sustained response endpoint is correlated with translation failure (SRC\u2009=\u2009-0.20, <jats:italic>p<\/jats:italic>-value\u2009=\u20091.53 \u00d7 10<jats:sup>\u221254<\/jats:sup>), and explainability analysis of multi-variate random forest models shows that both sustained response endpoint and subject age are negative predictors of translation success. We have developed a recommendation system to help plan the right preclinical study given factors such as drug dosage, bacterial dosage, and preclinical\/clinical endpoint. With an accuracy of 0.76 (F1 score of 0.71) and by using only 7 features (out of 68 total), the proposed system boosts translational efficiency by 25%. The method presented can extend to any disease and can serve as a preclinical to clinical translation decision support system to accelerate drug discovery and de-risk clinical outcomes.<\/jats:p>","DOI":"10.3389\/frai.2024.1487335","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T05:10:41Z","timestamp":1728450641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting clinical trial success for Clostridium difficile infections based on preclinical data"],"prefix":"10.3389","volume":"7","author":[{"given":"Fangzhou","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Millsop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Tagkopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.artint.2021.103502","article-title":"Explaining individual predictions when features are dependent: more accurate approximations to Shapley values","volume":"298","author":"Aas","year":"2021","journal-title":"Artif. Intell."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/cts.13055","article-title":"Opportunities and challenges in translational science","volume":"14","author":"Austin","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4161\/gmic.19526","article-title":"Models for the study of Clostridium difficile infection","volume":"3","author":"Best","year":"2012","journal-title":"Gut Microbes"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J. Artif. Intell. Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/ajg.2013.407","article-title":"How drugs are developed and approved by the FDA: current process and future directions","volume":"109","author":"Ciociola","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/idoj.IDOJ_475_18","article-title":"Indian","volume":"10","author":"Clinical","year":"2019","journal-title":"Dermatol. Online J."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"065","DOI":"10.1055\/s-0035-1547333","article-title":"Persistent and recurrent Clostridium difficile colitis","volume":"28","author":"Cole","year":"2015","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1093\/bioinformatics\/bty945","article-title":"Genetic neural networks: an artificial neural network architecture for capturing gene expression relationships","volume":"35","author":"Eetemadi","year":"2019","journal-title":"Bioinformatics"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s42256-024-00876-w","article-title":"A bioactivity foundation model using pairwise meta-learning","volume":"6","author":"Feng","year":"2024","journal-title":"Nat. Mach. Intell."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/jcss.1997.1504","article-title":"A decision-theoretic generalization of on-line learning and an application to boosting","volume":"55","author":"Freund","year":"1997","journal-title":"J. Comput. Syst. Sci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.chembiol.2016.07.023","article-title":"A data-driven approach to predicting successes and failures of clinical trials","volume":"23","author":"Gayvert","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/B978-0-08-051055-2.50029-8","article-title":"20- CONNECTIONIST LEARNING PROCEDURES11This chapter appeared in volume 40 of artificial intelligence in 1989, reprinted with permission of North-Holland publishing. It is a revised version of technical report CMU-CS-87-115, which has the same title and was prepared in June 1987 while the author was at Carnegie Mellon University. The research was supported by contract N00014-86-K-00167 from the Office of Naval Research and by grant IST-8520359 from the National Science Foundation","volume":"1","author":"Hinton","year":"1990","journal-title":"Mach. Learn."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1086\/502550","article-title":"The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance","volume":"26","author":"Kaye","year":"2005","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1101\/gr.648603","article-title":"Spectral biclustering of microarray data: coclustering genes and conditions","volume":"13","author":"Kluger","year":"2003","journal-title":"Genome Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/bioinformatics\/btz682","article-title":"Bio BERT: a pre-trained biomedical language representation model for biomedical text mining","volume":"36","author":"Lee","year":"2019","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.48550\/arXiv.1606.03490","article-title":"The mythos of model interpretability","volume":"2017","author":"Lipton","year":"2017","journal-title":"Comput. Sci."},{"key":"ref23","author":"Liu","year":"2023"},{"key":"ref24","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e201800098","DOI":"10.26508\/lsa.201800098","article-title":"An integrative machine learning approach for prediction of toxicity-related drug safety","volume":"1","author":"Lysenko","year":"2018","journal-title":"Life Sci. Alliance"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pnpbp.2012.08.020","article-title":"Physiologic complexity and aging: implications for physical function and rehabilitation","volume":"45","author":"Manor","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile disease: epidemiology and Clinical characteristics","volume":"20","author":"McFarland","year":"1999","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R & D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.48550\/arXiv.1201.0490","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.21105\/joss.00638","article-title":"MLxtend: providing machine learning and data science utilities and extensions to Python\u2019s scientific computing stack","volume":"3","author":"Raschka","year":"2018","journal-title":"J. Open Source Softw."},{"key":"ref31","author":"Satopaa","year":"2011"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-019-0148-3","article-title":"Artificial intelligence and machine learning in clinical development: a translational perspective","volume":"2","author":"Shah","year":"2019","journal-title":"NPJ Digit. Med."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.20","article-title":"Clostridium difficile infection","volume":"2","author":"Smits","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis","volume":"322","author":"Teasley","year":"1983","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ebiom.2019.08.027","article-title":"Looking beyond the hype: applied AI and machine learning in translational medicine","volume":"47","author":"Toh","year":"2019","journal-title":"EBioMedicine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2147\/IDR.S207572","article-title":"Recent advances in the treatment of C. difficile using biotherapeutic agents","volume":"12","author":"Van Giau","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref40","author":"Vaswani","year":"2017"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/biostatistics\/kxx030","article-title":"Adding experimental arms to platform clinical trials: randomization procedures and interim analyses","volume":"19","author":"Ventz","year":"2018","journal-title":"Biostatistics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0234722","DOI":"10.1371\/journal.pone.0234722","article-title":"A systematic review of machine learning models for predicting outcomes of stroke with structured data","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"ref43","first-page":"422","article-title":"Translational research: current status, challenges and future strategies","volume":"3","author":"Yu","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/PPO.0b013e3181be231d","article-title":"Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy","volume":"15","author":"Zhuang","year":"2009","journal-title":"Cancer J."}],"container-title":["Frontiers in Artificial Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2024.1487335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T05:10:46Z","timestamp":1728450646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2024.1487335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":45,"alternative-id":["10.3389\/frai.2024.1487335"],"URL":"https:\/\/doi.org\/10.3389\/frai.2024.1487335","relation":{},"ISSN":["2624-8212"],"issn-type":[{"value":"2624-8212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"article-number":"1487335"}}